Company Filing History:
Years Active: 2024
Title: Jeanne Allinne: Innovator in Inflammatory Condition Treatments
Introduction
Jeanne Allinne is a prominent inventor based in Paris, France. She has made significant contributions to the field of medical treatments, particularly in addressing inflammatory conditions of the airway and lungs. Her innovative work has led to the development of methods that utilize monoclonal antibodies to target specific interleukins.
Latest Patents
Jeanne Allinne holds a patent for her invention titled "Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor." This patent outlines methods for treating inflammatory diseases associated with elevated levels of IL-33 and IL-4, particularly focusing on inflammatory lung disorders. The invention provides a therapeutic approach by administering IL-33 antagonists alone or in combination with IL-4R antagonists to subjects in need.
Career Highlights
Allinne is currently associated with Regeneron Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work is pivotal in creating effective treatments for patients suffering from inflammatory diseases.
Collaborations
Jeanne collaborates with esteemed colleagues, including Jamie M Orengo and Andrew J Murphy, to further enhance the impact of her research in the medical field.
Conclusion
Jeanne Allinne's innovative contributions to the treatment of inflammatory conditions highlight her role as a leading inventor in the medical industry. Her dedication to improving patient outcomes through targeted therapies is commendable.